ACHIEVE LIFE SCIENCES, INC. 4

Waldman Reid Alexander received option and RSU awards for a total of 41,700 shares of Achieve Life Sciences, Inc. common stock as equity compensation.

On July 27, 2026, reporting person Waldman Reid Alexander received an equity compensation package from Achieve Life Sciences, Inc. consisting of a stock option grant for 25,000 shares of common stock at an exercise price of $6.18 per share and a restricted stock unit (RSU) award for 16,700 shares. Both the option and RSU awards vest 100% on the earlier of July 27, 2027 or immediately prior to the issuer’s 2027 annual stockholders’ meeting, contingent on continued service to the company. These are routine equity awards and do not reflect any open-market purchases or sales; following the grant, Alexander holds 41,700 derivative-based rights to common stock, with the eventual value dependent on the company’s share price at vesting and exercise.

Filing Facts

CIK

949858

Ticker

ACHV

Form

4

Source Type

fda

Accession

0001193125-26-324250

Alert Tier

5